FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry” was released on October 2, 2019 and recommends that CTS modify our current HCV reflex testing algorithm to support these best practices. The new algorithm will take effect on April 20, 2020.
Check out the Communication page for the complete details by clicking the link: Communications
On December 9, 2019, the new CTS Laboratory Information System successfully implemented in Phoe...
Honor Your StaffCelebrate Lab Week, and honor yourself and your colleagues as a vital part of the la...
On June 13, 2019, the new CTS Laboratory Information System was successfully implemented in Cha...
On January 25, 2021, CTS implements the Ortho VIP viral marker testing platform. Conversion from the...
CTS implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The newly...
As winter weather continues to move through parts of the US, we would like to remind you it may be n...